LifeStance Health Group, Inc. (NASDAQ: LFST) Stock Competitors & Peer Comparison
See LFST's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for LFST and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| LFST | $11.84 | +0.34% | 4.6B | 89.18 | $0.13 | N/A |
| HCA | $435.61 | +2.86% | 94.3B | 15.05 | $28.96 | +0.71% |
| THC | $259.71 | +4.08% | 20.9B | 15.06 | $17.24 | N/A |
| EHC | $123.47 | +1.20% | 12.2B | 21.14 | $5.84 | +0.62% |
| FMS | $22.69 | +1.52% | 12.2B | 8.53 | $2.66 | +3.82% |
| DVA | $178.47 | +2.18% | 11.5B | 13.94 | $12.80 | N/A |
| UHS | $178.86 | +1.06% | 10.8B | 7.93 | $22.54 | +0.45% |
| ENSG | $175.18 | +1.10% | 10.2B | 25.39 | $6.90 | +0.15% |
| OSH | $39.00 | +0.08% | 9.5B | -17.65 | -$2.21 | N/A |
| CHE | $512.16 | +3.33% | 6.7B | 23.71 | $21.61 | +0.49% |
Stock Comparison
HCA Healthcare, Inc. (NYSE: HCA)
LFST vs HCA Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, HCA has a market cap of 94.3B. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while HCA trades at $435.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas HCA's P/E ratio is 15.05. In terms of profitability, LFST's ROE is +0.03%, compared to HCA's ROE of -1.13%. Regarding short-term risk, LFST is less volatile compared to HCA. This indicates lower risk in terms of short-term price fluctuations for LFST.Check HCA's competition here
Tenet Healthcare Corporation (NYSE: THC)
LFST vs THC Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, THC has a market cap of 20.9B. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while THC trades at $259.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas THC's P/E ratio is 15.06. In terms of profitability, LFST's ROE is +0.03%, compared to THC's ROE of +0.51%. Regarding short-term risk, LFST is less volatile compared to THC. This indicates lower risk in terms of short-term price fluctuations for LFST.Check THC's competition here
Encompass Health Corporation (NYSE: EHC)
LFST vs EHC Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, EHC has a market cap of 12.2B. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while EHC trades at $123.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas EHC's P/E ratio is 21.14. In terms of profitability, LFST's ROE is +0.03%, compared to EHC's ROE of +0.25%. Regarding short-term risk, LFST is more volatile compared to EHC. This indicates higher risk in terms of short-term price fluctuations for LFST.Check EHC's competition here
Fresenius Medical Care AG & Co. KGaA (NYSE: FMS)
LFST vs FMS Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, FMS has a market cap of 12.2B. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while FMS trades at $22.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas FMS's P/E ratio is 8.53. In terms of profitability, LFST's ROE is +0.03%, compared to FMS's ROE of +0.07%. Regarding short-term risk, LFST is more volatile compared to FMS. This indicates higher risk in terms of short-term price fluctuations for LFST.Check FMS's competition here
DaVita Inc. (NYSE: DVA)
LFST vs DVA Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, DVA has a market cap of 11.5B. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while DVA trades at $178.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas DVA's P/E ratio is 13.94. In terms of profitability, LFST's ROE is +0.03%, compared to DVA's ROE of -1.24%. Regarding short-term risk, LFST is less volatile compared to DVA. This indicates lower risk in terms of short-term price fluctuations for LFST.Check DVA's competition here
Universal Health Services, Inc. (NYSE: UHS)
LFST vs UHS Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, UHS has a market cap of 10.8B. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while UHS trades at $178.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas UHS's P/E ratio is 7.93. In terms of profitability, LFST's ROE is +0.03%, compared to UHS's ROE of +0.21%. Regarding short-term risk, LFST is more volatile compared to UHS. This indicates higher risk in terms of short-term price fluctuations for LFST.Check UHS's competition here
The Ensign Group, Inc. (NASDAQ: ENSG)
LFST vs ENSG Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, ENSG has a market cap of 10.2B. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while ENSG trades at $175.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas ENSG's P/E ratio is 25.39. In terms of profitability, LFST's ROE is +0.03%, compared to ENSG's ROE of +0.17%. Regarding short-term risk, LFST is more volatile compared to ENSG. This indicates higher risk in terms of short-term price fluctuations for LFST.Check ENSG's competition here
Oak Street Health, Inc. (NYSE: OSH)
LFST vs OSH Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, OSH has a market cap of 9.5B. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while OSH trades at $39.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas OSH's P/E ratio is -17.65. In terms of profitability, LFST's ROE is +0.03%, compared to OSH's ROE of +4.64%. Regarding short-term risk, LFST is more volatile compared to OSH. This indicates higher risk in terms of short-term price fluctuations for LFST.Check OSH's competition here
Chemed Corporation (NYSE: CHE)
LFST vs CHE Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, CHE has a market cap of 6.7B. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while CHE trades at $512.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas CHE's P/E ratio is 23.71. In terms of profitability, LFST's ROE is +0.03%, compared to CHE's ROE of +0.29%. Regarding short-term risk, LFST is less volatile compared to CHE. This indicates lower risk in terms of short-term price fluctuations for LFST.Check CHE's competition here
Hims & Hers Health, Inc. (NYSE: HIMS)
LFST vs HIMS Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, HIMS has a market cap of 6.6B. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while HIMS trades at $29.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas HIMS's P/E ratio is -45.98. In terms of profitability, LFST's ROE is +0.03%, compared to HIMS's ROE of -0.30%. Regarding short-term risk, LFST is less volatile compared to HIMS. This indicates lower risk in terms of short-term price fluctuations for LFST.Check HIMS's competition here
PACS Group, Inc. (NYSE: PACS)
LFST vs PACS Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, PACS has a market cap of 6.5B. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while PACS trades at $41.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas PACS's P/E ratio is 21.85. In terms of profitability, LFST's ROE is +0.03%, compared to PACS's ROE of +0.27%. Regarding short-term risk, LFST is more volatile compared to PACS. This indicates higher risk in terms of short-term price fluctuations for LFST.Check PACS's competition here
LHC Group, Inc. (NASDAQ: LHCG)
LFST vs LHCG Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, LHCG has a market cap of 5.3B. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while LHCG trades at $169.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas LHCG's P/E ratio is 82.83. In terms of profitability, LFST's ROE is +0.03%, compared to LHCG's ROE of +0.04%. Regarding short-term risk, LFST is more volatile compared to LHCG. This indicates higher risk in terms of short-term price fluctuations for LFST.Check LHCG's competition here
Concentra Group Holdings Parent, Inc. (NYSE: CON)
LFST vs CON Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, CON has a market cap of 4.5B. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while CON trades at $35.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas CON's P/E ratio is 22.02. In terms of profitability, LFST's ROE is +0.03%, compared to CON's ROE of +0.47%. Regarding short-term risk, LFST is more volatile compared to CON. This indicates higher risk in terms of short-term price fluctuations for LFST.Check CON's competition here
National HealthCare Corporation (AMEX: NHC)
LFST vs NHC Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, NHC has a market cap of 3.5B. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while NHC trades at $227.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas NHC's P/E ratio is 28.86. In terms of profitability, LFST's ROE is +0.03%, compared to NHC's ROE of +0.13%. Regarding short-term risk, LFST is less volatile compared to NHC. This indicates lower risk in terms of short-term price fluctuations for LFST.Check NHC's competition here
Option Care Health, Inc. (NASDAQ: OPCH)
LFST vs OPCH Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, OPCH has a market cap of 3.5B. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while OPCH trades at $23.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas OPCH's P/E ratio is 13.41. In terms of profitability, LFST's ROE is +0.03%, compared to OPCH's ROE of +0.16%. Regarding short-term risk, LFST is more volatile compared to OPCH. This indicates higher risk in terms of short-term price fluctuations for LFST.Check OPCH's competition here
Amedisys, Inc. (NASDAQ: AMED)
LFST vs AMED Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, AMED has a market cap of 3.3B. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while AMED trades at $100.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas AMED's P/E ratio is 39.30. In terms of profitability, LFST's ROE is +0.03%, compared to AMED's ROE of +0.11%. Regarding short-term risk, LFST is more volatile compared to AMED. This indicates higher risk in terms of short-term price fluctuations for LFST.Check AMED's competition here
Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH)
LFST vs AVAH Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, AVAH has a market cap of 2.7B. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while AVAH trades at $12.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas AVAH's P/E ratio is 18.25. In terms of profitability, LFST's ROE is +0.03%, compared to AVAH's ROE of +1.50%. Regarding short-term risk, LFST is less volatile compared to AVAH. This indicates lower risk in terms of short-term price fluctuations for LFST.Check AVAH's competition here
Brookdale Senior Living Inc. (NYSE: BKD)
LFST vs BKD Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, BKD has a market cap of 2.7B. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while BKD trades at $11.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas BKD's P/E ratio is -19.15. In terms of profitability, LFST's ROE is +0.03%, compared to BKD's ROE of +4.06%. Regarding short-term risk, LFST is less volatile compared to BKD. This indicates lower risk in terms of short-term price fluctuations for LFST.Check BKD's competition here
Guardian Pharmacy Services, Inc. (NYSE: GRDN)
LFST vs GRDN Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, GRDN has a market cap of 2.6B. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while GRDN trades at $41.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas GRDN's P/E ratio is 36.64. In terms of profitability, LFST's ROE is +0.03%, compared to GRDN's ROE of +0.31%. Regarding short-term risk, LFST is less volatile compared to GRDN. This indicates lower risk in terms of short-term price fluctuations for LFST.Check GRDN's competition here
Acadia Healthcare Company, Inc. (NASDAQ: ACHC)
LFST vs ACHC Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, ACHC has a market cap of 2.6B. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while ACHC trades at $28.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas ACHC's P/E ratio is 14.12. In terms of profitability, LFST's ROE is +0.03%, compared to ACHC's ROE of -0.50%. Regarding short-term risk, LFST is less volatile compared to ACHC. This indicates lower risk in terms of short-term price fluctuations for LFST.Check ACHC's competition here
Pediatrix Medical Group, Inc. (NYSE: MD)
LFST vs MD Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, MD has a market cap of 2.2B. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while MD trades at $26.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas MD's P/E ratio is 11.75. In terms of profitability, LFST's ROE is +0.03%, compared to MD's ROE of +0.20%. Regarding short-term risk, LFST is less volatile compared to MD. This indicates lower risk in terms of short-term price fluctuations for LFST.Check MD's competition here
Addus HomeCare Corporation (NASDAQ: ADUS)
LFST vs ADUS Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, ADUS has a market cap of 2.1B. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while ADUS trades at $113.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas ADUS's P/E ratio is 16.94. In terms of profitability, LFST's ROE is +0.03%, compared to ADUS's ROE of +0.10%. Regarding short-term risk, LFST is more volatile compared to ADUS. This indicates higher risk in terms of short-term price fluctuations for LFST.Check ADUS's competition here
Select Medical Holdings Corporation (NYSE: SEM)
LFST vs SEM Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, SEM has a market cap of 2B. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while SEM trades at $16.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas SEM's P/E ratio is 15.43. In terms of profitability, LFST's ROE is +0.03%, compared to SEM's ROE of +0.08%. Regarding short-term risk, LFST is more volatile compared to SEM. This indicates higher risk in terms of short-term price fluctuations for LFST.Check SEM's competition here
Surgery Partners, Inc. (NASDAQ: SGRY)
LFST vs SGRY Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, SGRY has a market cap of 1.9B. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while SGRY trades at $14.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas SGRY's P/E ratio is 36.92. In terms of profitability, LFST's ROE is +0.03%, compared to SGRY's ROE of -0.05%. Regarding short-term risk, LFST is less volatile compared to SGRY. This indicates lower risk in terms of short-term price fluctuations for LFST.Check SGRY's competition here
Apollo Medical Holdings, Inc. (NASDAQ: AMEH)
LFST vs AMEH Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, AMEH has a market cap of 1.8B. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while AMEH trades at $40.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas AMEH's P/E ratio is 39.25. In terms of profitability, LFST's ROE is +0.03%, compared to AMEH's ROE of +0.05%. Regarding short-term risk, LFST is less volatile compared to AMEH. This indicates lower risk in terms of short-term price fluctuations for LFST.Check AMEH's competition here
Astrana Health, Inc. (NASDAQ: ASTH)
LFST vs ASTH Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, ASTH has a market cap of 1.8B. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while ASTH trades at $36.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas ASTH's P/E ratio is 43.82. In terms of profitability, LFST's ROE is +0.03%, compared to ASTH's ROE of +0.05%. Regarding short-term risk, LFST is less volatile compared to ASTH. This indicates lower risk in terms of short-term price fluctuations for LFST.Check ASTH's competition here
Sonida Senior Living, Inc. (NYSE: SNDA)
LFST vs SNDA Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, SNDA has a market cap of 1.8B. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while SNDA trades at $37.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas SNDA's P/E ratio is -6.09. In terms of profitability, LFST's ROE is +0.03%, compared to SNDA's ROE of -0.26%. Regarding short-term risk, LFST is more volatile compared to SNDA. This indicates higher risk in terms of short-term price fluctuations for LFST.Check SNDA's competition here
Nutex Health, Inc. (NASDAQ: NUTX)
LFST vs NUTX Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, NUTX has a market cap of 1.5B. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while NUTX trades at $220.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas NUTX's P/E ratio is 8.71. In terms of profitability, LFST's ROE is +0.03%, compared to NUTX's ROE of +0.52%. Regarding short-term risk, LFST is less volatile compared to NUTX. This indicates lower risk in terms of short-term price fluctuations for LFST.Check NUTX's competition here
Ardent Health Inc. (NYSE: ARDT)
LFST vs ARDT Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, ARDT has a market cap of 1.5B. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while ARDT trades at $10.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas ARDT's P/E ratio is 8.52. In terms of profitability, LFST's ROE is +0.03%, compared to ARDT's ROE of +0.05%. Regarding short-term risk, LFST is less volatile compared to ARDT. This indicates lower risk in terms of short-term price fluctuations for LFST.Check ARDT's competition here
Healthcare Services Group, Inc. (NASDAQ: HCSG)
LFST vs HCSG Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, HCSG has a market cap of 1.4B. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while HCSG trades at $21.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas HCSG's P/E ratio is 16.84. In terms of profitability, LFST's ROE is +0.03%, compared to HCSG's ROE of +0.24%. Regarding short-term risk, LFST is more volatile compared to HCSG. This indicates higher risk in terms of short-term price fluctuations for LFST.Check HCSG's competition here
The Pennant Group, Inc. (NASDAQ: PNTG)
LFST vs PNTG Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, PNTG has a market cap of 1.4B. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while PNTG trades at $40.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas PNTG's P/E ratio is 30.89. In terms of profitability, LFST's ROE is +0.03%, compared to PNTG's ROE of +0.10%. Regarding short-term risk, LFST is less volatile compared to PNTG. This indicates lower risk in terms of short-term price fluctuations for LFST.Check PNTG's competition here
Agilon Health, Inc. (NYSE: AGL)
LFST vs AGL Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, AGL has a market cap of 1.3B. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while AGL trades at $80.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas AGL's P/E ratio is -5.25. In terms of profitability, LFST's ROE is +0.03%, compared to AGL's ROE of -1.19%. Regarding short-term risk, LFST is less volatile compared to AGL. This indicates lower risk in terms of short-term price fluctuations for LFST.Check AGL's competition here
AMN Healthcare Services, Inc. (NYSE: AMN)
LFST vs AMN Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, AMN has a market cap of 1.3B. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while AMN trades at $34.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas AMN's P/E ratio is 11.47. In terms of profitability, LFST's ROE is +0.03%, compared to AMN's ROE of +0.15%. Regarding short-term risk, LFST is more volatile compared to AMN. This indicates higher risk in terms of short-term price fluctuations for LFST.Check AMN's competition here
U.S. Physical Therapy, Inc. (NYSE: USPH)
LFST vs USPH Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, USPH has a market cap of 1.3B. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while USPH trades at $84.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas USPH's P/E ratio is 33.43. In terms of profitability, LFST's ROE is +0.03%, compared to USPH's ROE of -0.01%. Regarding short-term risk, LFST is more volatile compared to USPH. This indicates higher risk in terms of short-term price fluctuations for LFST.Check USPH's competition here
Brookdale Senior Living Inc. 7. (NYSE: BKDT)
LFST vs BKDT Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, BKDT has a market cap of 1.2B. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while BKDT trades at $77.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas BKDT's P/E ratio is N/A. In terms of profitability, LFST's ROE is +0.03%, compared to BKDT's ROE of +4.06%. Regarding short-term risk, LFST is more volatile compared to BKDT. This indicates higher risk in terms of short-term price fluctuations for LFST.Check BKDT's competition here
Innovage Holding Corp. (NASDAQ: INNV)
LFST vs INNV Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, INNV has a market cap of 1.2B. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while INNV trades at $9.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas INNV's P/E ratio is -450.00. In terms of profitability, LFST's ROE is +0.03%, compared to INNV's ROE of -0.01%. Regarding short-term risk, LFST is less volatile compared to INNV. This indicates lower risk in terms of short-term price fluctuations for LFST.Check INNV's competition here
Talkspace, Inc. (NASDAQ: TALK)
LFST vs TALK Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, TALK has a market cap of 879.4M. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while TALK trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas TALK's P/E ratio is 774.34. In terms of profitability, LFST's ROE is +0.03%, compared to TALK's ROE of +0.00%. Regarding short-term risk, LFST is more volatile compared to TALK. This indicates higher risk in terms of short-term price fluctuations for LFST.Check TALK's competition here
Enhabit, Inc. (NYSE: EHAB)
LFST vs EHAB Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, EHAB has a market cap of 706.9M. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while EHAB trades at $13.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas EHAB's P/E ratio is -197.14. In terms of profitability, LFST's ROE is +0.03%, compared to EHAB's ROE of -0.01%. Regarding short-term risk, LFST is more volatile compared to EHAB. This indicates higher risk in terms of short-term price fluctuations for LFST.Check EHAB's competition here
Starling Oncology, Inc. (NASDAQ: STLN)
LFST vs STLN Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, STLN has a market cap of 665.9M. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while STLN trades at $6.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas STLN's P/E ratio is -21.82. In terms of profitability, LFST's ROE is +0.03%, compared to STLN's ROE of +2.10%. Regarding short-term risk, LFST is less volatile compared to STLN. This indicates lower risk in terms of short-term price fluctuations for LFST.Check STLN's competition here
GMR Solutions Inc. (NYSE: GMRS)
LFST vs GMRS Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, GMRS has a market cap of 599.5M. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while GMRS trades at $11.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas GMRS's P/E ratio is -5.47. In terms of profitability, LFST's ROE is +0.03%, compared to GMRS's ROE of +0.16%. Regarding short-term risk, LFST is less volatile compared to GMRS. This indicates lower risk in terms of short-term price fluctuations for LFST.Check GMRS's competition here
The Oncology Institute, Inc. (NASDAQ: TOI)
LFST vs TOI Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, TOI has a market cap of 512.9M. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while TOI trades at $5.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas TOI's P/E ratio is -14.25. In terms of profitability, LFST's ROE is +0.03%, compared to TOI's ROE of +2.10%. Regarding short-term risk, LFST is less volatile compared to TOI. This indicates lower risk in terms of short-term price fluctuations for LFST.Check TOI's competition here
Strata Critical Medical, Inc. (NASDAQ: SRTA)
LFST vs SRTA Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, SRTA has a market cap of 461.2M. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while SRTA trades at $5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas SRTA's P/E ratio is -25.12. In terms of profitability, LFST's ROE is +0.03%, compared to SRTA's ROE of +0.14%. Regarding short-term risk, LFST is less volatile compared to SRTA. This indicates lower risk in terms of short-term price fluctuations for LFST.Check SRTA's competition here
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA)
LFST vs MCTA Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, MCTA has a market cap of 445.6M. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while MCTA trades at $29.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas MCTA's P/E ratio is 419.36. In terms of profitability, LFST's ROE is +0.03%, compared to MCTA's ROE of -2.33%. Regarding short-term risk, LFST is more volatile compared to MCTA. This indicates higher risk in terms of short-term price fluctuations for LFST.Check MCTA's competition here
Community Health Systems, Inc. (NYSE: CYH)
LFST vs CYH Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, CYH has a market cap of 413.9M. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while CYH trades at $2.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas CYH's P/E ratio is 4.02. In terms of profitability, LFST's ROE is +0.03%, compared to CYH's ROE of +0.21%. Regarding short-term risk, LFST is less volatile compared to CYH. This indicates lower risk in terms of short-term price fluctuations for LFST.Check CYH's competition here
Auna S.A. (NYSE: AUNA)
LFST vs AUNA Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, AUNA has a market cap of 378.3M. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while AUNA trades at $5.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas AUNA's P/E ratio is 4.60. In terms of profitability, LFST's ROE is +0.03%, compared to AUNA's ROE of +0.01%. Regarding short-term risk, LFST is less volatile compared to AUNA. This indicates lower risk in terms of short-term price fluctuations for LFST.Check AUNA's competition here
Viemed Healthcare, Inc. (NASDAQ: VMD)
LFST vs VMD Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, VMD has a market cap of 339.4M. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while VMD trades at $8.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas VMD's P/E ratio is 24.75. In terms of profitability, LFST's ROE is +0.03%, compared to VMD's ROE of +0.10%. Regarding short-term risk, LFST is less volatile compared to VMD. This indicates lower risk in terms of short-term price fluctuations for LFST.Check VMD's competition here
Capital Senior Living Corporation (NYSE: CSU)
LFST vs CSU Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, CSU has a market cap of 223.7M. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while CSU trades at $33.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas CSU's P/E ratio is 0.67. In terms of profitability, LFST's ROE is +0.03%, compared to CSU's ROE of -0.33%. Regarding short-term risk, LFST is less volatile compared to CSU. This indicates lower risk in terms of short-term price fluctuations for LFST.Check CSU's competition here
AirSculpt Technologies, Inc. (NASDAQ: AIRS)
LFST vs AIRS Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, AIRS has a market cap of 138.3M. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while AIRS trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas AIRS's P/E ratio is -65.33. In terms of profitability, LFST's ROE is +0.03%, compared to AIRS's ROE of -0.13%. Regarding short-term risk, LFST is less volatile compared to AIRS. This indicates lower risk in terms of short-term price fluctuations for LFST.Check AIRS's competition here
The Joint Corp. (NASDAQ: JYNT)
LFST vs JYNT Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, JYNT has a market cap of 117.3M. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while JYNT trades at $8.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas JYNT's P/E ratio is 82.30. In terms of profitability, LFST's ROE is +0.03%, compared to JYNT's ROE of +0.22%. Regarding short-term risk, LFST is more volatile compared to JYNT. This indicates higher risk in terms of short-term price fluctuations for LFST.Check JYNT's competition here
Five Star Senior Living Inc. (NASDAQ: FVE)
LFST vs FVE Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, FVE has a market cap of 98.4M. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while FVE trades at $2.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas FVE's P/E ratio is -5.64. In terms of profitability, LFST's ROE is +0.03%, compared to FVE's ROE of -0.15%. Regarding short-term risk, LFST is less volatile compared to FVE. This indicates lower risk in terms of short-term price fluctuations for LFST.Check FVE's competition here
Kindly MD, Inc. (NASDAQ: KDLYW)
LFST vs KDLYW Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, KDLYW has a market cap of 96.5M. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while KDLYW trades at $18.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas KDLYW's P/E ratio is N/A. In terms of profitability, LFST's ROE is +0.03%, compared to KDLYW's ROE of -1.05%. Regarding short-term risk, LFST is less volatile compared to KDLYW. This indicates lower risk in terms of short-term price fluctuations for LFST.Check KDLYW's competition here
Park Dental Partners, Inc. Common Stock (NASDAQ: PARK)
LFST vs PARK Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, PARK has a market cap of 91.5M. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while PARK trades at $19.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas PARK's P/E ratio is 27.39. In terms of profitability, LFST's ROE is +0.03%, compared to PARK's ROE of -0.18%. Regarding short-term risk, LFST is less volatile compared to PARK. This indicates lower risk in terms of short-term price fluctuations for LFST.Check PARK's competition here
biote Corp. (NASDAQ: BTMD)
LFST vs BTMD Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, BTMD has a market cap of 53.8M. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while BTMD trades at $1.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas BTMD's P/E ratio is 11.09. In terms of profitability, LFST's ROE is +0.03%, compared to BTMD's ROE of -0.09%. Regarding short-term risk, LFST is less volatile compared to BTMD. This indicates lower risk in terms of short-term price fluctuations for LFST.Check BTMD's competition here
AlerisLife Inc. (NASDAQ: ALR)
LFST vs ALR Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, ALR has a market cap of 44.2M. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while ALR trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas ALR's P/E ratio is -1.11. In terms of profitability, LFST's ROE is +0.03%, compared to ALR's ROE of -0.15%. Regarding short-term risk, LFST is more volatile compared to ALR. This indicates higher risk in terms of short-term price fluctuations for LFST.Check ALR's competition here
DocGo Inc. (NASDAQ: DCGO)
LFST vs DCGO Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, DCGO has a market cap of 34M. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while DCGO trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas DCGO's P/E ratio is -0.18. In terms of profitability, LFST's ROE is +0.03%, compared to DCGO's ROE of -1.16%. Regarding short-term risk, LFST is less volatile compared to DCGO. This indicates lower risk in terms of short-term price fluctuations for LFST.Check DCGO's competition here
EUDA Health Holdings Limited (NASDAQ: EUDA)
LFST vs EUDA Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, EUDA has a market cap of 33.4M. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while EUDA trades at $17.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas EUDA's P/E ratio is -12.03. In terms of profitability, LFST's ROE is +0.03%, compared to EUDA's ROE of +1.20%. Regarding short-term risk, LFST is less volatile compared to EUDA. This indicates lower risk in terms of short-term price fluctuations for LFST.Check EUDA's competition here
Cryo-Cell International, Inc. (AMEX: CCEL)
LFST vs CCEL Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, CCEL has a market cap of 33.1M. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while CCEL trades at $4.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas CCEL's P/E ratio is -13.70. In terms of profitability, LFST's ROE is +0.03%, compared to CCEL's ROE of +0.14%. Regarding short-term risk, LFST is more volatile compared to CCEL. This indicates higher risk in terms of short-term price fluctuations for LFST.Check CCEL's competition here
IMAC Holdings, Inc. (NASDAQ: IMAC)
LFST vs IMAC Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, IMAC has a market cap of 33.1M. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while IMAC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas IMAC's P/E ratio is -2.27. In terms of profitability, LFST's ROE is +0.03%, compared to IMAC's ROE of +0.00%. Regarding short-term risk, LFST is less volatile compared to IMAC. This indicates lower risk in terms of short-term price fluctuations for LFST.Check IMAC's competition here
P3 Health Partners Inc. (NASDAQ: PIII)
LFST vs PIII Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, PIII has a market cap of 23.1M. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while PIII trades at $7.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas PIII's P/E ratio is -0.21. In terms of profitability, LFST's ROE is +0.03%, compared to PIII's ROE of +1.61%. Regarding short-term risk, LFST is less volatile compared to PIII. This indicates lower risk in terms of short-term price fluctuations for LFST.Check PIII's competition here
Cano Health, Inc. (NYSE: CANO-WT)
LFST vs CANO-WT Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, CANO-WT has a market cap of 19.3M. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while CANO-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas CANO-WT's P/E ratio is N/A. In terms of profitability, LFST's ROE is +0.03%, compared to CANO-WT's ROE of -1.49%. Regarding short-term risk, LFST is less volatile compared to CANO-WT. This indicates lower risk in terms of short-term price fluctuations for LFST.Check CANO-WT's competition here
Aesthetic Medical International Holdings Group Limited (NASDAQ: AIH)
LFST vs AIH Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, AIH has a market cap of 15.9M. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while AIH trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas AIH's P/E ratio is -2.78. In terms of profitability, LFST's ROE is +0.03%, compared to AIH's ROE of +1.16%. Regarding short-term risk, LFST is less volatile compared to AIH. This indicates lower risk in terms of short-term price fluctuations for LFST.Check AIH's competition here
P3 Health Partners Inc. (NASDAQ: PIIIW)
LFST vs PIIIW Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, PIIIW has a market cap of 12.9M. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while PIIIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas PIIIW's P/E ratio is N/A. In terms of profitability, LFST's ROE is +0.03%, compared to PIIIW's ROE of +1.61%. Regarding short-term risk, LFST is more volatile compared to PIIIW. This indicates higher risk in terms of short-term price fluctuations for LFST.Check PIIIW's competition here
Cano Health, Inc. (NYSE: CANO)
LFST vs CANO Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, CANO has a market cap of 12.4M. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while CANO trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas CANO's P/E ratio is -0.01. In terms of profitability, LFST's ROE is +0.03%, compared to CANO's ROE of -1.49%. Regarding short-term risk, LFST is less volatile compared to CANO. This indicates lower risk in terms of short-term price fluctuations for LFST.Check CANO's competition here
Avem Health Partners, Inc. (NYSE: FPCG)
LFST vs FPCG Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, FPCG has a market cap of 10.1M. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while FPCG trades at $1,025.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas FPCG's P/E ratio is 0.09. In terms of profitability, LFST's ROE is +0.03%, compared to FPCG's ROE of +0.00%. Regarding short-term risk, LFST is more volatile compared to FPCG. This indicates higher risk in terms of short-term price fluctuations for LFST.Check FPCG's competition here
Field Trip Health Ltd. (NASDAQ: FTRP)
LFST vs FTRP Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, FTRP has a market cap of 9.8M. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while FTRP trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas FTRP's P/E ratio is -1.22. In terms of profitability, LFST's ROE is +0.03%, compared to FTRP's ROE of -0.62%. Regarding short-term risk, LFST is less volatile compared to FTRP. This indicates lower risk in terms of short-term price fluctuations for LFST.Check FTRP's competition here
American Shared Hospital Services (AMEX: AMS)
LFST vs AMS Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, AMS has a market cap of 9.4M. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while AMS trades at $1.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas AMS's P/E ratio is -5.64. In terms of profitability, LFST's ROE is +0.03%, compared to AMS's ROE of -0.07%. Regarding short-term risk, LFST is less volatile compared to AMS. This indicates lower risk in terms of short-term price fluctuations for LFST.Check AMS's competition here
ModivCare Inc. (NASDAQ: MODV)
LFST vs MODV Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, MODV has a market cap of 6.2M. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while MODV trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas MODV's P/E ratio is -0.06. In terms of profitability, LFST's ROE is +0.03%, compared to MODV's ROE of +1.36%. Regarding short-term risk, LFST is more volatile compared to MODV. This indicates higher risk in terms of short-term price fluctuations for LFST.Check MODV's competition here
Basel Medical Group Ltd Ordinary Shares (NASDAQ: BMGL)
LFST vs BMGL Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, BMGL has a market cap of 5.8M. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while BMGL trades at $3.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas BMGL's P/E ratio is -0.70. In terms of profitability, LFST's ROE is +0.03%, compared to BMGL's ROE of -1.74%. Regarding short-term risk, LFST is less volatile compared to BMGL. This indicates lower risk in terms of short-term price fluctuations for LFST.Check BMGL's competition here
Greenbrook TMS Inc. (NASDAQ: GBNH)
LFST vs GBNH Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, GBNH has a market cap of 5.5M. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while GBNH trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas GBNH's P/E ratio is -0.06. In terms of profitability, LFST's ROE is +0.03%, compared to GBNH's ROE of +15.74%. Regarding short-term risk, LFST is less volatile compared to GBNH. This indicates lower risk in terms of short-term price fluctuations for LFST.Check GBNH's competition here
20/20 Biolabs Inc. (NASDAQ: AIDX)
LFST vs AIDX Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, AIDX has a market cap of 5.3M. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while AIDX trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas AIDX's P/E ratio is -0.81. In terms of profitability, LFST's ROE is +0.03%, compared to AIDX's ROE of -3.87%. Regarding short-term risk, LFST is less volatile compared to AIDX. This indicates lower risk in terms of short-term price fluctuations for LFST.Check AIDX's competition here
Regional Health Properties, Inc. (AMEX: RHE-PA)
LFST vs RHE-PA Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, RHE-PA has a market cap of 5.2M. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while RHE-PA trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas RHE-PA's P/E ratio is -0.09. In terms of profitability, LFST's ROE is +0.03%, compared to RHE-PA's ROE of +1.09%. Regarding short-term risk, LFST is less volatile compared to RHE-PA. This indicates lower risk in terms of short-term price fluctuations for LFST.Check RHE-PA's competition here
Regional Health Properties, Inc. (AMEX: RHE)
LFST vs RHE Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, RHE has a market cap of 5.2M. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while RHE trades at $2.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas RHE's P/E ratio is -1.79. In terms of profitability, LFST's ROE is +0.03%, compared to RHE's ROE of -1.31%. Regarding short-term risk, LFST is less volatile compared to RHE. This indicates lower risk in terms of short-term price fluctuations for LFST.Check RHE's competition here
The Oncology Institute, Inc. (NASDAQ: TOIIW)
LFST vs TOIIW Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, TOIIW has a market cap of 4.7M. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while TOIIW trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas TOIIW's P/E ratio is -0.17. In terms of profitability, LFST's ROE is +0.03%, compared to TOIIW's ROE of +2.10%. Regarding short-term risk, LFST is more volatile compared to TOIIW. This indicates higher risk in terms of short-term price fluctuations for LFST.Check TOIIW's competition here
Starling Oncology Inc. Wt (NASDAQ: STLNW)
LFST vs STLNW Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, STLNW has a market cap of 4M. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while STLNW trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas STLNW's P/E ratio is -0.13. In terms of profitability, LFST's ROE is +0.03%, compared to STLNW's ROE of +2.10%. Regarding short-term risk, LFST is less volatile compared to STLNW. This indicates lower risk in terms of short-term price fluctuations for LFST.Check STLNW's competition here
IMAC Holdings, Inc. (NASDAQ: IMACW)
LFST vs IMACW Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, IMACW has a market cap of 1.7M. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while IMACW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas IMACW's P/E ratio is N/A. In terms of profitability, LFST's ROE is +0.03%, compared to IMACW's ROE of +0.73%. Regarding short-term risk, LFST is less volatile compared to IMACW. This indicates lower risk in terms of short-term price fluctuations for LFST.Check IMACW's competition here
Endovia Health Sciences, Inc. (AMEX: EDVA)
LFST vs EDVA Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, EDVA has a market cap of 1.2M. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while EDVA trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas EDVA's P/E ratio is -0.01. In terms of profitability, LFST's ROE is +0.03%, compared to EDVA's ROE of N/A. Regarding short-term risk, LFST is less volatile compared to EDVA. This indicates lower risk in terms of short-term price fluctuations for LFST.Check EDVA's competition here
EUDA Health Holdings Limited (NASDAQ: EUDAW)
LFST vs EUDAW Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, EUDAW has a market cap of 1.1M. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while EUDAW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas EUDAW's P/E ratio is -0.02. In terms of profitability, LFST's ROE is +0.03%, compared to EUDAW's ROE of +1.20%. Regarding short-term risk, LFST is more volatile compared to EUDAW. This indicates higher risk in terms of short-term price fluctuations for LFST.Check EUDAW's competition here
Concord Medical Services Holdings Limited (NYSE: CCM)
LFST vs CCM Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, CCM has a market cap of 524.2K. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while CCM trades at $3.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas CCM's P/E ratio is -1.21. In terms of profitability, LFST's ROE is +0.03%, compared to CCM's ROE of +0.06%. Regarding short-term risk, LFST is less volatile compared to CCM. This indicates lower risk in terms of short-term price fluctuations for LFST.Check CCM's competition here
NewGenIvf Group Limited (NASDAQ: NIVFW)
LFST vs NIVFW Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, NIVFW has a market cap of 43.9K. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while NIVFW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas NIVFW's P/E ratio is N/A. In terms of profitability, LFST's ROE is +0.03%, compared to NIVFW's ROE of +0.33%. Regarding short-term risk, LFST is less volatile compared to NIVFW. This indicates lower risk in terms of short-term price fluctuations for LFST.Check NIVFW's competition here
NewGenIvf Group Limited (NASDAQ: NIVF)
LFST vs NIVF Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, NIVF has a market cap of 35.9K. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while NIVF trades at $0.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas NIVF's P/E ratio is 0.28. In terms of profitability, LFST's ROE is +0.03%, compared to NIVF's ROE of +0.33%. Regarding short-term risk, LFST is less volatile compared to NIVF. This indicates lower risk in terms of short-term price fluctuations for LFST.Check NIVF's competition here
Talkspace, Inc. (NASDAQ: TALKW)
LFST vs TALKW Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, TALKW has a market cap of 33.5K. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while TALKW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas TALKW's P/E ratio is 0.00. In terms of profitability, LFST's ROE is +0.03%, compared to TALKW's ROE of +0.00%. Regarding short-term risk, LFST is less volatile compared to TALKW. This indicates lower risk in terms of short-term price fluctuations for LFST.Check TALKW's competition here
Mobile-health Network Solutions Class A Ordinary Shares (NASDAQ: MNDR)
LFST vs MNDR Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, MNDR has a market cap of 33.5K. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while MNDR trades at $1.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas MNDR's P/E ratio is -0.03. In terms of profitability, LFST's ROE is +0.03%, compared to MNDR's ROE of -0.46%. Regarding short-term risk, LFST is less volatile compared to MNDR. This indicates lower risk in terms of short-term price fluctuations for LFST.Check MNDR's competition here
Tenon Medical, Inc. (NASDAQ: TNONW)
LFST vs TNONW Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, TNONW has a market cap of 6.2K. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while TNONW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas TNONW's P/E ratio is N/A. In terms of profitability, LFST's ROE is +0.03%, compared to TNONW's ROE of N/A. Regarding short-term risk, LFST is less volatile compared to TNONW. This indicates lower risk in terms of short-term price fluctuations for LFST.Check TNONW's competition here
Tivity Health, Inc. (NASDAQ: TVTY)
LFST vs TVTY Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, TVTY has a market cap of 0. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while TVTY trades at $32.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas TVTY's P/E ratio is 19.06. In terms of profitability, LFST's ROE is +0.03%, compared to TVTY's ROE of +1.75%. Regarding short-term risk, LFST is more volatile compared to TVTY. This indicates higher risk in terms of short-term price fluctuations for LFST.Check TVTY's competition here
Skylight Health Group Inc. (NASDAQ: SLHGP)
LFST vs SLHGP Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, SLHGP has a market cap of 0. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while SLHGP trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas SLHGP's P/E ratio is -30.38. In terms of profitability, LFST's ROE is +0.03%, compared to SLHGP's ROE of -0.48%. Regarding short-term risk, LFST is more volatile compared to SLHGP. This indicates higher risk in terms of short-term price fluctuations for LFST.Check SLHGP's competition here
Kindred Healthcare, Inc. (NYSE: KND)
LFST vs KND Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, KND has a market cap of 0. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while KND trades at $9.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas KND's P/E ratio is -1.14. In terms of profitability, LFST's ROE is +0.03%, compared to KND's ROE of -0.53%. Regarding short-term risk, LFST is more volatile compared to KND. This indicates higher risk in terms of short-term price fluctuations for LFST.Check KND's competition here
ATI Physical Therapy, Inc. (NYSE: ATIP-WT)
LFST vs ATIP-WT Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, ATIP-WT has a market cap of 0. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while ATIP-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas ATIP-WT's P/E ratio is N/A. In terms of profitability, LFST's ROE is +0.03%, compared to ATIP-WT's ROE of +2.05%. Regarding short-term risk, LFST is less volatile compared to ATIP-WT. This indicates lower risk in terms of short-term price fluctuations for LFST.Check ATIP-WT's competition here
Almost Family Inc. (NASDAQ: AFAM)
LFST vs AFAM Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, AFAM has a market cap of 0. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while AFAM trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas AFAM's P/E ratio is N/A. In terms of profitability, LFST's ROE is +0.03%, compared to AFAM's ROE of +0.06%. Regarding short-term risk, LFST is less volatile compared to AFAM. This indicates lower risk in terms of short-term price fluctuations for LFST.Check AFAM's competition here
SOC Telemed, Inc. (NASDAQ: TLMD)
LFST vs TLMD Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, TLMD has a market cap of 0. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while TLMD trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas TLMD's P/E ratio is -1.60. In terms of profitability, LFST's ROE is +0.03%, compared to TLMD's ROE of -0.46%. Regarding short-term risk, LFST is more volatile compared to TLMD. This indicates higher risk in terms of short-term price fluctuations for LFST.Check TLMD's competition here
Hanger, Inc. (NYSE: HNGR)
LFST vs HNGR Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, HNGR has a market cap of 0. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while HNGR trades at $18.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas HNGR's P/E ratio is 19.71. In terms of profitability, LFST's ROE is +0.03%, compared to HNGR's ROE of +0.52%. Regarding short-term risk, LFST is more volatile compared to HNGR. This indicates higher risk in terms of short-term price fluctuations for LFST.Check HNGR's competition here
DocGo Inc. (NASDAQ: DCGOW)
LFST vs DCGOW Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, DCGOW has a market cap of 0. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while DCGOW trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas DCGOW's P/E ratio is N/A. In terms of profitability, LFST's ROE is +0.03%, compared to DCGOW's ROE of -1.16%. Regarding short-term risk, LFST is less volatile compared to DCGOW. This indicates lower risk in terms of short-term price fluctuations for LFST.Check DCGOW's competition here
SOC Telemed, Inc. (NASDAQ: TLMDW)
LFST vs TLMDW Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, TLMDW has a market cap of 0. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while TLMDW trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas TLMDW's P/E ratio is N/A. In terms of profitability, LFST's ROE is +0.03%, compared to TLMDW's ROE of -0.46%. Regarding short-term risk, LFST is less volatile compared to TLMDW. This indicates lower risk in terms of short-term price fluctuations for LFST.Check TLMDW's competition here
Skylight Health Group Inc. (NASDAQ: SLHG)
LFST vs SLHG Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, SLHG has a market cap of 0. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while SLHG trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas SLHG's P/E ratio is -1.48. In terms of profitability, LFST's ROE is +0.03%, compared to SLHG's ROE of N/A. Regarding short-term risk, LFST is less volatile compared to SLHG. This indicates lower risk in terms of short-term price fluctuations for LFST.Check SLHG's competition here
Diversicare Healthcare Services, Inc. (NASDAQ: DVCR)
LFST vs DVCR Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, DVCR has a market cap of 0. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while DVCR trades at $10.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas DVCR's P/E ratio is 28.34. In terms of profitability, LFST's ROE is +0.03%, compared to DVCR's ROE of -0.15%. Regarding short-term risk, LFST is more volatile compared to DVCR. This indicates higher risk in terms of short-term price fluctuations for LFST.Check DVCR's competition here
New Frontier Health Corporation (NYSE: NFH)
LFST vs NFH Comparison September 2026
LifeStance Health Group, Inc. (NASDAQ: LFST) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LFST stands at 4.6B. In comparison, NFH has a market cap of 0. Regarding current trading prices, LFST is priced at $11.84 on the NASDAQ, while NFH trades at $11.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LFST currently has a P/E ratio of 89.18, whereas NFH's P/E ratio is -19.75. In terms of profitability, LFST's ROE is +0.03%, compared to NFH's ROE of -0.06%. Regarding short-term risk, LFST is more volatile compared to NFH. This indicates higher risk in terms of short-term price fluctuations for LFST.Check NFH's competition here